| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/12/2008 | WO2007103134A3 Prolongation of survival of an allograft by inhibiting complement activity |
| 09/12/2008 | WO2007089945A3 Treating diseases by targeting silt3 |
| 09/12/2008 | WO2006113623A3 Elimination of heterogeneous or mixed cell population in tumors |
| 09/12/2008 | WO2005091856A8 Asthma-related anti-il-13 immunoglobulin derived proteins, compositions, methods and uses |
| 09/12/2008 | CA2680227A1 Compositions and methods for the prevention and treatment of autoimmune conditions |
| 09/12/2008 | CA2680161A1 Pharmaceutical composition |
| 09/12/2008 | CA2680060A1 Double-stranded locked nucleic acid compositions |
| 09/12/2008 | CA2680038A1 Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections |
| 09/12/2008 | CA2679983A1 Bacterial extract for digestive or urinary tract disorders and process for its preparation |
| 09/12/2008 | CA2679765A1 T4 bacteriophage bound to a substrate |
| 09/12/2008 | CA2679743A1 Methods and compositions involving polymeric immunoglobulin fusion proteins |
| 09/12/2008 | CA2679548A1 Methods and compositions for treating tumor diseases |
| 09/12/2008 | CA2679410A1 Novel method and compositions |
| 09/12/2008 | CA2678888A1 Human antibodies against hepatitis c virus (hcv) and uses thereof |
| 09/12/2008 | CA2678628A1 Recombinant antibodies for treatment of respiratory syncytial virus infections |
| 09/12/2008 | CA2678555A1 Amelioration of cellular stress response |
| 09/12/2008 | CA2677108A1 Predicting response to a her inhibitor |
| 09/12/2008 | CA2668018A1 Immunogenic and therapeutic compositions for streptococcus pyogenes |
| 09/11/2008 | US20080221309 MN Gene and Protein |
| 09/11/2008 | US20080220078 Pharmaceutical Formulations |
| 09/11/2008 | US20080220077 injectable compositions comprising biocompatible, swellable, substantially hydrophilic, non-toxic and substantially spherical polymeric material carriers which are capable of efficiently delivering bioactive therapeutic factor(s) for use in embolization drug therapy |
| 09/11/2008 | US20080220072 Biologic modulations with nanoparticles |
| 09/11/2008 | US20080220056 Treatment for liver disease |
| 09/11/2008 | US20080220049 Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins |
| 09/11/2008 | US20080220048 implantable medical equipment coated with biocompatible polymers based on modified [1,4]oxazepan-7-one, used as in situ time-release agents or drug delivery devices; prevention of restenosis, aneurysms and plaque |
| 09/11/2008 | US20080220046 Terpolymers for Controlled Release of Bioactive Agents From Implantable Medical Devices |
| 09/11/2008 | US20080220028 vaccines comprising an antigen and a self-adjuvanting carrier, useful for inducing antigen-specific mucosal and systemic immune responses in the host upon immunization |
| 09/11/2008 | US20080220025 grafting a mixture of alloactivated lymphocytes in a compatible drug excipient, in or around a tumor site, to elicite an antitumor immunology response; cellular immunology and cancer therapy |
| 09/11/2008 | US20080220024 Antifungal vaccines with saccharomyces cerevisiae |
| 09/11/2008 | US20080220023 Antifungal vaccines with saccharomyces cerevisiae |
| 09/11/2008 | US20080220022 kits for vaccination of poultry, comprising bottles and package inserts with administration instructions; the bottles comprise an attenuated and an inactivated immunogens, excipients, diluents or vehicles |
| 09/11/2008 | US20080220021 Topical Botulinum Toxin Compositions for the Treatment of Hyperhidrosis |
| 09/11/2008 | US20080220020 Transdermal Botulinum Toxin Compositions |
| 09/11/2008 | US20080220019 in a cell culture, for use as antibodies or vaccines against hepatitis virus; genetic engineering |
| 09/11/2008 | US20080220018 administering deactivated or attenuated Streptococcus zooepidemicus, immunogenic fragment of S. zooepidemicus and/or nucleotide codes for the fragment; immunology; veterinary medicine |
| 09/11/2008 | US20080220017 administering modified virus particles having reduced lipid content, drugs carriers and immunostimulants, to provide protection against infection by viral diseases |
| 09/11/2008 | US20080220016 Method of Treating and Preventing Infectious Diseases via Creation of a Modified Viral Particle with Immunogenic Properties |
| 09/11/2008 | US20080220015 Method of modulating neutralizing antibodies formation in mammals, and uses thereof in gene therapy, animal trangenesis and in functional inactivation of endogenous proteins |
| 09/11/2008 | US20080220014 Recombinant viral-based malaria vaccines |
| 09/11/2008 | US20080220013 Diagnostic Method for Brain Damage-Related Disorders |
| 09/11/2008 | US20080220012 Induce host immune response against a multi-epitopic in vivo antigen; does not elicit an effective host immune response; binding agent non-radiolabeled; form binding agent/antigen pair; host immune response elicited against a second epitope on the antigen |
| 09/11/2008 | US20080220011 Flagellin/tumor antigen fusion for use in induction of immune response to cancer antigen; tissue targeted therapy; antitumor agents |
| 09/11/2008 | US20080220010 Mixture comprising two or more Group B streptococcal antigens for use in generating vaccines against infection |
| 09/11/2008 | US20080220009 Composition comprising hepadnavirus core antigen for use in preparing vaccines against hepatitis infection |
| 09/11/2008 | US20080220008 Mutated Hiv Nef For Modulating Immunity |
| 09/11/2008 | US20080220007 Ehrlichia canis genes and vaccines |
| 09/11/2008 | US20080220006 Method for Modulating Inflammatory Responses |
| 09/11/2008 | US20080220005 Comb Polymers |
| 09/11/2008 | US20080220004 Administering fusion proteins, immunoglobulins, and multimeric proteins; pharmacokinetics; age-related macular degeneration and diabetic retinopathy |
| 09/11/2008 | US20080220003 C5a Receptor Antagonists |
| 09/11/2008 | US20080220002 Modified transferin-antibody fusion proteins |
| 09/11/2008 | US20080220001 Using heterocyclic sulfonamide specific to carbonic anhydrase as therapeutic tools in treatment of tumor disorders |
| 09/11/2008 | US20080220000 Methods for Generating Improved Immune Reponse |
| 09/11/2008 | US20080219999 Immunoadhesin for the prevention of rhinovirus infection |
| 09/11/2008 | US20080219998 Anticoagulant for use in treatment and prevention of thrombosis or thrombin-dependent vaso-occlusive disease; selective reduction of intravascular thromboplastin antecedent activity |
| 09/11/2008 | US20080219997 Her-2 binding antagonists |
| 09/11/2008 | US20080219996 Modulating expression of bone sialoprotein in non-small cell lung cancer tumor as indicator of progression |
| 09/11/2008 | US20080219995 Il-32 monoclonal antibodies and uses thereof |
| 09/11/2008 | US20080219994 Modified bouganin proteins, cytotoxins and methods and uses thereof |
| 09/11/2008 | US20080219993 RalGDS related (RGR) protein specific immunoglobulin for treatment and prevention of cell proliferative disorders |
| 09/11/2008 | US20080219992 Pancreatic protein for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 09/11/2008 | US20080219991 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219990 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219989 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 09/11/2008 | US20080219988 Polypeptide comprising major histocompatibility complex epitopes for targeting and destroying tumor cells |
| 09/11/2008 | US20080219987 Amino acid sequences associated with cell cycle regulating proteins (CDC25b) for use as immunoglobulin targets in treatment of breast and pancreatic tumors; immunotherapy |
| 09/11/2008 | US20080219986 Neisserial protein for use in diagnosis, prevention and treatment of microorganismal infection |
| 09/11/2008 | US20080219985 Prok2 antagonists and methods of use |
| 09/11/2008 | US20080219984 Nucleotide sequences coding myelin-associated glycoprotein receptor for use in identifying modulators for treatment of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease |
| 09/11/2008 | US20080219983 Antihemophilic factor specific peptides for use as therapeutic tools in treatment of blood disorders |
| 09/11/2008 | US20080219982 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219981 Solid cancer antigenic polypeptide for use in designing and identifying modulators for prevention and treatment of tumorous masses |
| 09/11/2008 | US20080219980 Bi-Specific Complexes for Targeting Cells Involved in Allergic-Type Reactions, Compositions and Uses Thereof |
| 09/11/2008 | US20080219979 Using cytokine receptor specific immunoglobulin as therapeutic tool in treatment and prevention of inflammatory, nervous system, skin and autoimmune disorders |
| 09/11/2008 | US20080219978 Using Fc gamma RIA polypeptide as therapeuticin treatment and prevention of autoimmune, connective tissue and inflammatory disorders |
| 09/11/2008 | US20080219977 Combinations Comprising Gemcitabine and Tyrosine Kinase Inhibitors for the Treatment of Pancreatic Cancer |
| 09/11/2008 | US20080219976 Methods and compositions for treatment and prevention of staphylococcal infections |
| 09/11/2008 | US20080219975 Vegfr3 inhibitors |
| 09/11/2008 | US20080219974 Transmembrane glycoprotein specific immunoglobulin for use in diagnosis, prevention and treatment of autoimmune diseases |
| 09/11/2008 | US20080219973 Using antigalectin-3 immunoglobulin as therapeutic in prevention and treatment of glomerulonephritis, diabetic nephropathy and/or tissue fibrosis |
| 09/11/2008 | US20080219972 Prostatic Acid Phosphatase (Pap) Materials and Methods of Use Thereof in the Prophylactic and Therapeutic Treatment of Prostate Cancer |
| 09/11/2008 | US20080219971 Leukocyte semaphorin specific immunoglobulin for use in prevention and treatment of inflammation, autoimmune, skin, nervous system and/or cell roliferative disorders |
| 09/11/2008 | US20080219970 Identification and molecular characterisation of proteins, expressed in the ixodes ricinus salivary glands |
| 09/11/2008 | US20080219969 Concentrate of Chikungunya-Specific Immunoglobulins as a Medicinal Product |
| 09/11/2008 | US20080219968 Son of sevenless homolog 1 (SOS1) suppressive agent for prevention and treatment of cell proliferative disorders |
| 09/11/2008 | US20080219967 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological diseases |
| 09/11/2008 | US20080219954 Viral vector comprising adenovirus capsid gene sequences for use as tool for delivery and expression of heterologous gene sequences in cells |
| 09/11/2008 | US20080219953 Cosmid dna constructs and methods of making and using same |
| 09/11/2008 | US20080219951 Fluid mixture for enhancing implantable drug delivery at body temperature |
| 09/11/2008 | US20080219925 Delta opioid receptor protein |
| 09/11/2008 | US20080219924 Imaging, diagnosis and treatment of disease |
| 09/11/2008 | US20080219920 Chimeric, Human and Humanized Anti-CSAP Monoclonal Antibodies |
| 09/11/2008 | US20080219919 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 09/10/2008 | EP1967591A2 Method of assessing the usefulness of a test compound for alleviating a pneumococcal infection in an animal |
| 09/10/2008 | EP1967586A1 84P2A9: A prostate and testis specific protein highly expressed in prostate cancer |
| 09/10/2008 | EP1967529A1 Anti-rhesus D recombinant polyclonal antibody and methods of manufacture |
| 09/10/2008 | EP1967528A2 CDR-Grafted type III anti-cea humanized mouse monoclonal antibodies |
| 09/10/2008 | EP1967525A2 A method for regulating immune function in primates using the foxp3 protein |
| 09/10/2008 | EP1967209A1 Therapeutic agent for prostate cancer |
| 09/10/2008 | EP1967207A1 Inhibitor of cytotoxic t cell induction |